anti-alg2 (R&D Systems)
R&D Systems is a verified supplier 
R&D Systems manufactures this product 
90
Structured Review
R&D Systems
anti-alg2
Anti Alg2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+alg2/anti+alg2/pmc11221835-263-119-120
Average 90 stars, based on 1 article reviews
Anti Alg2, supplied by R&D Systems, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+alg2/anti+alg2/pmc11221835-263-119-120
Average 90 stars, based on 1 article reviews
anti-alg2 - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: Oxidative stress-induced phosphorylation of JIP4 regulates lysosomal positioning in coordination with TRPML1 and ALG2. Article Snippet: Retrograde transport of lysosomes is recognised as a critical autophagy regulator.. Here, we found that acrolein, an aldehyde that is significantly elevated in Parkinson’s disease patient serum, enhances autophagy by promoting lysosomal clustering around the microtubule organising centre via a newly identified JIP4-TRPML1-ALG2 pathway.. Phosphorylation of JIP4 at T217 by CaMK2G in response to Ca fluxes tightly regulated this system. Article Title: Oxidative stress‐induced phosphorylation of JIP4 regulates lysosomal positioning in coordination with TRPML1 and ALG2 Article Snippet: The primary antibodies used were as follows: anti‐LC3B (Cell Signaling Technology Inc., Danvers, MA, AB_2137707), anti‐β‐actin (Merck Millipore, AB_2223041), anti‐phospho‐p70S6K (Cell Signaling Technology Inc. AB_2269803), anti‐p70S6K (Cell Signaling Technology Inc. AB_390722), anti‐phospho‐S6 (Cell Signaling Technology Inc., AB_916156), anti‐S6 (Cell Signaling Technology Inc. AB_331355), anti‐α‐tubulin antibody (Sigma‐Aldrich, AB_477583), Article Title: Identification of novel autophagy inducers by accelerating lysosomal clustering against Parkinson’s disease Article Snippet: The primary antibodies used were as follows: anti-LC3B (Cell Signaling Technology Inc., Danvers, MA, AB_2137707), anti-β-actin (Merck Millipore, AB_2223041), anti-phospho-mTORC1 (Ser2448) (Cell Signaling Technology Inc. AB_330970), anti-mTORC1 (Cell Signaling Technology Inc. AB_330978), anti-phospho-ULK1(Ser757) (Cell Signaling Technology Inc. AB_2665508), anti-ULK1 (Cell Signaling Technology Inc. AB_11178668), anti-phospho-p70S6K (Cell Signaling Technology Inc. AB_2269803), anti-p70S6K (Cell Signaling Technology Inc. AB_390722), anti-phospho-S6 (Cell Signaling Technology Inc., AB_916156), anti-S6 (Cell Signaling Technology Inc. AB_331355), anti-p62 (Abcam, AB_945626), anti-multi-ubiquitin (MBL, AB_592937), anti-FIP200 (D10D11) (Cell Signaling Technology Inc. AB_2797913), anti-GAPDH (Cell Signaling Technology Inc. AB_10622025), anti-TMEM55B (Proteintech, AB_2879391), |